<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>BMC Microbiology                                                                                                                         BioMed Central <br />  <br />  <br />  <br /> Research article                                                                                                                       Open Access <br /> Gene disruption DNA topoisomerase IB small subunit <br /> induces non-viable <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-163' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-165' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-209' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-237' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span>phenotype</span> hemoflagellate Leishmania <br /> major <br /> Rafael Bala&#195;&#177;a-Fouce*, Carlos Garc&#195;&#173;a-Estrada, Yolanda P&#195;&#169;rez-Pertejo and <br /> Rosa M Reguera <br />  <br /> Address: Departamento Farmacolog&#195;&#173;a y Toxicolog&#195;&#173;a (INTOXCAL), Universidad Le&#195;&#179;n, Campus Vegazana s/n; 24071 Le&#195;&#179;n, Spain <br /> Email: Rafael Bala&#195;&#177;a-Fouce* - rbalf@unileon.es; Carlos Garc&#195;&#173;a-Estrada - c.gestrada@unileon.es; Yolanda P&#195;&#169;rez-Pertejo - myperp@unileon.es; <br /> Rosa M Reguera - rmregt@unileon.es <br /> * Corresponding author <br />  <br />  <br />  <br />  <br /> Published: 8 July 2008                                                         Received: 5 February 2008 <br />                                                                                Accepted: 8 July 2008 <br /> BMC Microbiology 2008, 8:113   doi:10.1186/1471-2180-8-113 <br /> This article available <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span>: http://www.biomedcentral.com/1471-2180/8/113 <br /> &#194;&#169; 2008 Bala&#195;&#177;a-Fouce et al; licensee BioMed Central Ltd. <br /> This Open Access article distributed terms Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), <br /> which permits unrestricted use, distribution, reproduction medium, provided original work properly cited. <br />  <br />  <br />  <br />  <br />                  <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                  Background: The unusual heterodimeric leishmanial DNA topoisomerase IB consists large <br />                  subunit containing phylogenetically conserved &quot;core&quot; domain, small subunit harboring the <br />                  C-terminal region characteristic tyrosine residue active site. RNAi silencing any <br />                  protomers induces non-viable phenotype hemoflagelate Trypanosoma brucei. <br />                  Unfortunately, approach suitable Leishmania gene replacement an <br />                  antibiotic marker approach generate lack-of-function mutants. In work, have <br />                  successfully generated <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-156' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span>null mutants</span> small subunit L. major DNA topoisomerase IB using <br />                  selection markers, conferring resistance hygromycin B puromycin, respectively. <br />                  Results: We successfully replaced topS loci selection markers. However, <span id='am-3' about='protege:TO' typeof='owl:Thing'>to</span> <br />                  achieve second transfection round, rescue null-homozygous an <br />                  episomal vector carrying Leishmania major topS gene. Phenotypic characterization L. major <br />                  rescued strain L. major strain, co-overexpresses subunits, shows differences <br />                  DNA relaxation camptothecin cytotoxicity compared wild-type strain. <br />                  Studies phosphatidylserine externalization poor incidence camptothecin-induced <br />                  programmed cell death L. major, effective cell-cycle arrest occurs 24 h. S- <br />                  Phase delay G2/M reversible arrest main outcome lower concentrations, but <br />                  irreversible G2 arrest detected higher camptothecin pressure. <br />                  Conclusion: Results obtained work evidence essentiality topS gene encoding the <br />                  L. major DNA topoisomerase IB small subunit. Reversibility camptothecin effect points the <br />                  existence effective checkpoint mechanisms Leishmania parasites. <br />  <br />  <br />  <br />  <br /> Background                                                                      mosquito&apos;s bite-place [1]. The existing first-line therapies <br /> Leishmania major aetiological agent cutaneous                         based pentavalent antimonium salts antiquated <br /> leishmaniasis, zoonotic neglected tropical disease char-                      toxic [2]. Paromomycin-based ointments triazole <br /> acterized presence ulcerative skin lesions                     antifungal agents (fluconazole, itrakonazole ketoco- <br />  <br />  <br />                                                                                                                                        Page 1 14 <br />                                                                                                                  (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                               http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br /> nazole) variable limited efficacy [3] whereas,    somes treated specific inhibitor camptothecin <br /> clinical trials carried promising alkyl-phos-     (CPT) [18]. <br /> pholipid miltefosine [4] scarce. A recent report <br /> carried Iran concluded oral miltefosine        Inhibitors DNA topoisomerases represent major class <br /> apparently good pentavalent antimonium salts         anti-cancer drugs growing number in <br /> the treatment L. major cutaneous leishmaniasis [5].         clinical use [19]. Several studies shown CPT has <br />                                                                strong anti-trypanosomal anti-leishmanial activities <br /> In scenario urgent need new antileish-    vitro, inducing DNA-cleavable complexes sub- <br /> manial drug targets. DNA topoisomerases (Top) catalyze         micromolar range [20]. The outcome stable DNA cleav- <br /> changes superhelicity duplex DNA repli-       age generation single- double-stranded breaks, <br /> cation, transcription, recombination DNA repair            believed cause point mutations, fragmenta- <br /> processes [6,7]. Two families subfamilies DNA       tion genome eventually programmed cell death <br /> topoisomerases play pivotal role preserving DNA integ-       (PCD) [21]. <br /> rity living organisms. Type I Top (TopI) ATP- <br /> independent monomeric enzymes introducing transient            Since mechanism RNAi-mediated gene attenua- <br /> single-stranded breaks DNA, followed passage         tion functional Leishmania parasites [22], gen- <br /> rejoining. Type II Top (TopII) multimeric ATP hydro-       eration null-mutants feasible gene <br /> lyzing proteins generate temporary double-stranded        replacement techniques warranty total disruption <br /> breaks double helix, followed passage            target gene. The present work describes pheno- <br /> rejoining. TopII relaxes positively supercoiled       type null-mutant small subunit L. major <br /> DNA, displays catenation/decatenation knot-       TopIB, sensitivity CPT PCD induced by <br /> ting/unknotting activities. TopIA subfamily produces           inhibitor aetiological agent cutaneous leish- <br /> transient covalent bonds 5&apos; end broken DNA,      maniasis L. major. <br /> whereas TopIB subfamily specific cleavage polarity <br /> at 3&apos; end [8].                                             Results <br />                                                                Double targeted gene replacement LmTopS <br /> Unlike organisms studied present, TopIB        To asses biological involvement LmTopIB relax- <br /> trypanosomes leishmanias heterodimeric                 ation supercoiled DNA CPT susceptibility, tried <br /> enzymes [9-11]. Genetic analyses identified gene,            create null-mutant <span id='am-238' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-239' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-240' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-243' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-244' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-248' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-249' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-251' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-253' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-257' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-261' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-264' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-265' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-266' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-271' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-278' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-282' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-288' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-289' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-290' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-294' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-296' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-305' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-307' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-311' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-312' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span>knockout</span> topS locus dou- <br /> located L. donovani chromosome 34,                ble-targeted replacement antibiotic resistant cassettes <br /> encodes large subunit (LdTopIL) estimated            [23], kindly provided S.M. Beverley (Uni- <br /> molecular mass 73 kDa. This protein contains       versity Washington St. Louis, Mo USA). Since topS <br /> non-conserved N-terminus conserved cen-         gene encodes catalytic active site LmTopIB, the <br /> tral core domain enzyme, includes res-    effective disruption gene nullify biolog- <br /> idues interact DNA, DNA-cleaving          ical function entire enzyme. To purpose, we <br /> tyrosine. On hand, small subunit (LdTopIS)       created targeting plasmids pSK-topS-KO-HYG and <br /> is encoded second ORF located chromosome 4.            pSK-topS-KO-PAC. They contain respective antibiotic <br /> This ORF encodes 262-long polypeptide pre-            resistance cassettes flanked 1000-bp region that <br /> dicted molecular mass 28-kDa. This polypeptide con-         includes 5&apos; 3&apos; flanking regions topS <br /> tains phylogenetically conserved &quot;SKxxY&quot; motif,            gene (Fig. 1A). First, topS-allele replaced HYG- <br /> which includes Tyr-222 plays role DNA cleav-     resistance cassette create heterozygous strain <br /> age. [12]. This genomic organization confirmed soon        (&#206;&#8221;topS::HYG). Hybridization external probe (EP) <br /> after African trypanosomes [13] genes encod-        shows 1.7-kb XhoI fragment present genomic <br /> ing TopIB protomer annotated T.          DNA WT promastigotes additional 2.6-kb <br /> cruzi Genome Project [14].                                     fragment corresponding effective allele replace- <br />                                                                ment. Colonies isolated heterozygous strain <br /> As eukaryotic cells, TopIB TopII essential     perfectly viable used perform second <br /> to cell life [15,16]. Enzyme silencing T. brucei TopII   replacement round. When strain electroporated <br /> small <span id='am-316' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-317' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-318' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-319' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-320' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-322' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-323' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-324' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-325' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-327' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-331' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-332' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-333' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-334' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-335' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-336' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-339' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-340' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-342' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-343' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-345' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-346' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-347' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-349' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-350' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-355' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-356' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-358' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-360' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-361' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-362' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-364' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-365' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-367' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-371' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-373' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-375' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-376' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-377' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-378' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-379' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-383' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-385' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-387' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-388' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-389' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-391' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-392' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-393' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span> (RNAi) produces singular phe-         lineal pSK-topS-KO-PAC create homozygous <br /> notype lacking kDNA, called dyskinetoplasticy leads       (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC), set double resistant HYG/ <br /> to cell death [17]. Furthermore, RNAi-mediated silencing       PAC colonies obtained (clones 1 5), were <br /> of gene expression subunit TopIB results       able growth antibiotics selective pressure. South- <br /> drastic reduction DNA RNA synthesis Afri-       ern analysis isolated clones shows the <br /> can trypanosomes, mimicking inhibition nucleic          predicted 2.6 kb corresponding allele replace- <br /> acid biosynthesis observed bloodstream trypano-           ment, second 2.2 kb-long band corresponding the <br />  <br />  <br />                                                                                                                    Page 2 14 <br />                                                                                              (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                               http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                                             1.7 kb XhoI           0.7 kb XhoI <br />                                                                               X <br />                                                             X                          X <br />                                                                 EP <br />                                                                      UST topS DST <br />  <br />                                                                      X                            0.5 kb <br />                                                                                   EV <br />  <br />  <br />  <br />  <br />                                                                                     double genetic replacement <br />  <br />  <br />                                                                          2.6 kb <br />                                                             X                          X <br />                                                                 EP <br />  <br />                                                                           HYG <br />                                                                                                   0.5 kb <br />  <br />                                                                          2.2 kb <br />                                                             X                          X <br />                                                                 EP <br />                                                                           PAC <br />                                                                                                   0.5 kb <br />  <br />  <br />  <br />          External probe (EP)                                                               topS probe <br />                                       topS/ topS        topS/ topS+topS                                    topS/ topS          topS/ topS+topS <br />                       WT    (+/-) 1     2   3   4   5   1   2    3 4      5                WT   (+/-) 1     2     3   4    5   1    2    3 4    5 <br />               4.0 <br />               3.0 <br />  <br />               2.0 <br />    topS       1.5 <br />  <br />  <br />  <br />  <br /> Figure   1 <br /> Construction   L. major topS-null mutants (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC), double targeted gene replacement <br /> Construction L. major topS-null mutants (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC), double targeted gene replacement. A) Strategy tar- <br /> geted gene replacement. (Upper) The topS gene locus, location upstream (UST) downstream (DST) segments <br /> used target homologous recombination 1.7-kb XbaI restriction fragments. The disruption constructs shown imme- <br /> diately below, including UST DST fragments, XbaI EcoRV terminal polylinker restriction sites. The targeted <br /> gene replacement event indicated arrow, showing structure resulting chromosomal locus the <br /> predicted 2.6-kb 2.2-kb XbaI restriction fragments diagnostic correct homologous integration events. X, <br /> indicate XbaI restriction sites. Generation null-mutant required second targeted gene replacement using similar gene <br /> disruption cassette containing PAC marker. B) Southern blot containing 10 &#206;&#188;g genomic DNA WT parasites, hetero- <br /> zygous knockout line integration HYG gene disruption construct (+/-), (&#206;&#8221;topS/&#206;&#8221;topS) integration PAC, <br /> and (&#206;&#8221;topS/&#206;&#8221;topS+topS)after integration PAC clone previously transfected episomal vector pXG-topS carry- <br /> ing topS genehybridized radiolabeled probe represented white box located outside disruption region <br /> (external probe, EP). C) The blot shown B elution EP rehybridization topS probe. The numbers <br /> indicate positions sizes (kb pairs) DNA molecular weight markers. <br />  <br />  <br /> second gene substitution, present (Fig. 1B). However,                  pXG-topS construct, episomal plasmid expresses <br /> the 1.7-kb XhoI fragment, hybridizes EP,                    topS presence DHFR/TS locus L. <br /> still remains, showing unexpected trisomy topS                   major. This new strain used second replace- <br /> locus clones 1, 3, 4 5. To remove band, het-               ment. Under circumstances 1.7-kb band effec- <br /> erozygous (&#206;&#8221;topS::HYG) clone transfected                      tively disappeared isolated clones showing only <br />  <br />  <br />                                                                                                                                         Page 3 14 <br />                                                                                                                 (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br /> the 2.2 2.6-kb expected bands. They correspond       obtained (Fig. 5) leishmanial strains. The WT <br /> correct homologous integrations upstream down-              strain showed slower active relaxation activity <br /> stream topS locus. A Southern analysis clones     (Fig. 4A). Most substrate relaxed different <br /> obtained experiments using topS gene         topoisomers perceptible supercoiled DNA still <br /> as probe, shows effective replacement topS        remained 20 min higher protein concentra- <br /> alleles (lanes 8 12 Figure 1C), addition   tion. The relaxation activity strains was <br /> intense 3 kb band corresponding episomal topS            faster higher shown control. Figure <br /> gene required complement topoisomerase defi-             4B shows fully relaxed DNA 5 min LmTopIB- <br /> ciency. One clone representing new L. major strain         overexpressing strain, 4-fold higher activity (com- <br /> was called (&#206;&#8221;topS/&#206;&#8221;topS) + topS indicating rescued          paring lane 3 set B lane 1 set A). When the <br /> null-topS genotype.                                             LmTopIB-overexpressing strain compared the <br />                                                                 rescued (&#206;&#8221;topS/&#206;&#8221;topS) + topS knockout (Fig. 4C), differ- <br /> Western analyses WT, (&#206;&#8221;topS/&#206;&#8221;topS) + topS              ences time protein dilution observed. It <br /> LmTopIB overexpressing strains carried assess       remarkable scarce differences relaxation <br /> the expression rate TopIB genes. For purpose,       activity strains accordance lack of <br /> heterologous LdTopIL LdTopIS polyclonal rabbit              significant differences CPT cytotoxicity. <br /> antisera used hybridize transferred pro- <br /> teins SDS-PAGE. Figure 2A shows results               To determine phase cell cycle CPT <br /> obtained hybridization LdTopIL antiserum,            exerts growth inhibitory effect, exponentially growing <br /> which evidences significant 7-fold increase immu-      L. major promastigotes treated different concen- <br /> noreactive band corresponding LmTopIB-overex-            trations CPT 24 h analyzed flow cytometry. <br /> pressing strain. Figure 2B shows similar Western blot,        Submicromolar concentrations CPT did appear to <br /> but case nylon membrane hybridized         exert effect. A significant 51% S-phase arrest <br /> LdTopIS rabbit antiserum, showing ca. 7-fold overex-          appeared treatment 1 &#206;&#188;M CPT (&#206;&#8221;topS/ <br /> pression small subunit, LmTopIB-overex-          &#206;&#8221;topS) + topS strain, increased 64% the <br /> pressing (&#206;&#8221;topS/&#206;&#8221;topS) + topS extracts.                     presence 50 &#206;&#188;M CPT (Fig. 5). <br />  <br /> Phenotypic characterization genetically manipulated L.       To determine CPT-induced S-phase arrest <br /> major strains                                                   reversible, L. major promastigotes treated 24 h <br /> The phenotypic outcome genetic manipulation topS          induce S-phase arrest. Then CPT washed and <br /> locus evaluated rescued (&#206;&#8221;topS/&#206;&#8221;topS) + topS,        cells incubated fresh medium addi- <br /> LmTopIB overexpressing WT L. major strains. The             tional period 24 h (R24) 48 h (R48). CPT-treated WT <br /> growth rate strains analyzed 96 h         cells able revert cell-growth arrest lower <br /> span-time, 12 h stepwise, presence different con-     drug concentration (5 &#206;&#188;M) 24 h, arrest was <br /> centrations CPT (0.5 25 &#206;&#188;M). The proliferation rate       irreversible 50 &#206;&#188;M CPT 48 h drug with- <br /> was measured cell counting (Fig. 3A&#226;&#8364;&#8220;C) using Coul-         drawal (Fig. 6A). In case LmTopIB-overexpressing and <br /> ter apparatus. No significant differences growth rate        rescued-mutant (&#206;&#8221;topS/&#206;&#8221;topS) + topS strains, CPT induced <br /> were noticed strains study. The           irreversible S-phase arrest concentration tested <br /> higher growth WT promastigotes          (Figs. 6B 6C). <br /> either genetic manipulation exerted other <br /> two strains, probably continuous antibiotic      Progression cell cycle chemical synchroniza- <br /> selection pressure exerted culture medium main-       tion studied L. major promastigotes <br /> tain strains. CPT equally effective        strains. The use 5 mM HU, inhibitor ribonucle- <br /> strains; dose-response curves determined 48 h sub-        otide reductase, reversibly arrest DNA synthesis, has <br /> passages provided IC50 values 0.56 &#206;&#188;M, 0.39 &#206;&#188;M           previously reported [24]. After 12-h exposure to <br /> 0.30 &#206;&#188;M WT, (&#206;&#8221;topS/&#206;&#8221;topS) + topS LmTopIB over-          HU, percentages L. major promastigotes dif- <br /> expressing strains, respectively.                               ferent cell cycle phases were: 65% G1, 23% S and <br />                                                                 12% G2/M. Promastigotes underwent cell cycle progres- <br /> To evaluate topoisomerase activity displayed       sion HU removal, time required com- <br /> leishmanial strains, standard relaxation assays per-       plete cell cycle dependent genetic <br /> formed WT, (&#206;&#8221;topS/&#206;&#8221;topS) + topS LmTopIB over-          manipulation carried topS locus. Thus, WT <br /> expressing lysates coming log-phase cultures. Time-        phenotype needs 24 h complete cell cycle; time <br /> course (left lanes) lysate dilution (right lanes) experi-   longer LmTopIB-overexpressing strain, <br /> ments carried 37&#194;&#176;C. Under experimental        rescued-mutant (&#206;&#8221;topS/&#206;&#8221;topS) + topS com- <br /> conditions clear distributive relaxation <span id='am-394' about='xsp:pattern' typeof='owl:Thing'>pattern</span>          pleted cell-cycle progression shorter period 9 h. <br />  <br />  <br />                                                                                                                     Page 4 14 <br />                                                                                               (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                                       http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />                                                                                        PCD 24 h, extended incubation period 48 <br />  <br />  <br />  <br />  <br />                        LmTopIB overexpresing <br />                                                                                        h using 10 &#206;&#188;M CPT. Apoptosis assessed time <br />  <br />  <br />  <br />  <br />                                                ( topS/ topS) + topS <br />                                                                                        (Fig. 9). Surprisingly, significant differences were <br />                                                                                        observed strains. These results indicate that <br />                                                                                        CPT inducing PCD L. major cultures the <br />                                                                                        experimental conditions using lab. <br />  <br />                                                                                        Discussion <br />                                                                                        Double targeted gene replacement method choice <br />                                                                                        create defective null-mutants Leishmania parasites <br />              WT <br />  <br />  <br />  <br />  <br />                                                                                        [22]. A L. major TopIB-null mutant defective small <br />                                                                       hybridized to:   subunit enzyme (which contains DNA-cleaving <br />                                                                                        tyrosine) created assess role played this <br />    A                                                                  anti-topL        enzyme parasite <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span>survival</span> CPT resistance. Since no <br />                                                                                        colonies obtained repeatedly second round of <br />                                                                                        replacement, suspected gene essential Leish- <br />                                                                                        mania activity Top <br />    B                                                                  anti-topS        enzymes. The outcome incomplete replacement of <br />                                                                                        LmTopIB alleles selectable antibiotics the <br />                                                                                        emergence trisomies topS locus (lanes 1, 3, 4 and <br />                                                                       anti- -actin     5, Fig. 1), non-atypical phenomenon kineto- <br />    C                                                                                   plastids plasticity genome [25]. <br />                                                                                        Therefore, decided perform previous transforma- <br /> rum <br /> LdTopIS <br /> Figure <br /> WT, <br /> A)  B)  2 <br /> Expression <br /> hybridizing <br /> cuedWestern <br />         Similar <br />      strain,to analysis <br />                 to <br />          polyclonal <br />             ofusing <br />                 LmTopIB measuring <br />      LmTopIB-overexpressing <br />                    heterologous <br />                      aAheterologous <br />                        antiserum <br />                         butunder <br />                             hybridizing <br />                                  &#206;&#178;-actin <br />                                   and <br />                                  different <br />                                    TopIL <br />                                  C)      topolyclonal <br />                                       Similar <br />                                         (&#206;&#8221;topS/&#206;&#8221;topS) <br />                                      LdTopIL      A and <br />                                             protein <br />                                             agenetic    +BtopS <br />                                               heterologous <br />                                                topolyclonal <br />                                                      abundance <br />                                                       antiserum <br />                                                              of <br />                                                      manipulations <br />                                                             antise- <br />                                                                res-                    tion plasmid carrying target gene episomal <br /> Expression LmTopIB different genetic manipulations                            expression genetic complementation sec- <br /> A) Western analysis measuring TopIL protein abundance                               ond round genomic replacement. In case, suc- <br /> WT, LmTopIB-overexpressing (&#206;&#8221;topS/&#206;&#8221;topS) + topS res- <br />                                                                                        cessfully obtained colonies, topS <br /> cued strain, using heterologous LdTopIL polyclonal antise- <br /> rum B) Similar A hybridizing heterologous                                  allele replaced antibiotic marker. Essentiality <br /> LdTopIS polyclonal antiserum C) Similar A B                                 TopIB described Drosophila [15] mouse <br /> hybridizing heterologous &#206;&#178;-actin polyclonal antiserum.                            [16], outcome TopIB gene disruption a <br />                                                                                        dead phenotype. The budding yeast remarkable excep- <br />                                                                                        tion phenomenon [26]. S. cerevisiae-deficient <br /> These effects independent CPT treatment,                                 TopIB viable currently used important <br /> strongly suggest, genetic manip-                             tool gene expression foreign recombinant TopIB, <br /> ulation strains (Fig. 7).                                                       expression enzymes bacteria dif- <br />                                                                                        ficult feasible. <br /> Quantification PS externalization L. major <br /> promastigotes                                                                          Gene silencing TbTopIL TbTopIS genes carried <br /> As measure CPT-induced PCD L. major, FACS pro-                               Bakshi Shapiro [18] using RNAi. These authors <br /> cedure carried combining PI/annexin V double                                   indistinct phenotypes separately silenced <br /> stain. Promastigotes cultured presence different                            TbTopIL TbTopIS genes; detectable reduction ribos- <br /> concentrations CPT different time-points                             omal RNA levels specific messengers, <br /> the optimal conditions PCD. Figure 8 shows trans-                              growth arrest, decrease total nucleic acid biosynthesis <br /> location PS outer surface plasma membrane                              attributable reductions DNA- RNA-specific <br /> drug-treated promastigotes 0.1 &#206;&#188;M, 0.5 &#206;&#188;M, 1 &#206;&#188;M, 5 &#206;&#188;M                               synthesis. Absolute levels nuclear mitochondrial <br /> and 10 &#206;&#188;M CPT. The L. major strains used                                  transcripts reduced. In L. major single replace- <br /> study incubated different CPT concentrations                                 ment alleles originated heterozygous phe- <br /> during period 24 h submitted                                notype differentiable WT cell <br /> the double stain protocol. Panels slight increase                            growth CPT sensitivity. <br /> early late apoptosis (bottom upper-right sections <br /> of panel, respectively) regarding untreated cul-                              Neither promastigotes genetically rescued <br /> tures, barely rose CPT concentration. This                                  topS-null mutant ones TopIB overexpressing <br /> effect studied (&#206;&#8221;topS/&#206;&#8221;topS) + topS                                strain, showed different growth rates significant IC50 <br /> LmTopIB-overexpressing strains, scarcely increased                               values CPT. These unexpected results correlated well <br /> this parameter. Since CPT did significantly induce                                 relaxation activities extracts <br />  <br />  <br />                                                                                                                                           Page 5 14 <br />                                                                                                                     (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                                           http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                        50                                                  coordinated expression subunits neces- <br />                                                                                            sary African trypanosomes. RNAi silencing one <br />                                                 WT <br />  Cell growtn, promastigotes x 106/ml <br />  <br />  <br />  <br />  <br />                                                                                        A   TbTopIB protomers causes coordinated loss both <br />                                        40 <br />                                                                                            subunits [18]. The authors speculated individual <br />                                                                                            proteins stable association other, <br />                                        30                                                  unstable separated. <br />  <br />                                        20                                                  Several reports conclude TopIB overexpression does <br />                                                                                            involve higher relaxation activity CPT susceptibility <br />                                                                                            mammalian cells [27]. A recent paper describing the <br />                                        10 <br />                                                                                            transfection human TopIB gene OVCAR-3 cultures <br />                                                                                            &#226;&#8364;&#8220; ovarian cancer cell line &#226;&#8364;&#8220; shows that, despite effec- <br />                                         0                                                  tive seven-fold TopIB overexpression, sensitivity to <br />                                                                                            topotecan &#226;&#8364;&#8220; CPT hydrosoluble analogue &#226;&#8364;&#8220; not <br />                                                                                        B   improved compared control untransfected cells [28]. <br />  Cell growtn, promastigotes x 106/ml <br />  <br />  <br />  <br />  <br />                                        30       ( topS/ topS)+topS <br />                                                                                            This observation agrees similar levels TopIB <br />                                        25                                                  activity control overexpressing cells, point- <br />                                                                                            ing effective post-translational down-regulation <br />                                        20 <br />                                                                                            mechanism limiting TopIB activity supportable <br />                                        15                                                  values. These authors tempted speculate that <br />                                                                                            TopIB overexpression produces alteration phos- <br />                                        10                                                  phorylation state protein limits activity and <br />                                                                                            prevents improvement CPT response [29,30]. It very <br />                                         5                                                  likely dispensable 40 amino acids-long sequence <br />                                         0 <br />                                                                                            comprised Ser-96 Ser-135 N-ter- <br />                                                                                            minal extension LmTopIB small subunit con- <br />                                        30 <br />                                                 LmTopIB overexpressing                 C   tains 27 serine residues [31,32], suitable of <br />  Cell growtn, promastigotes x 106/ml <br />  <br />  <br />  <br />  <br />                                                                                            phosphorylation/dephosphorylation processes act- <br />                                        25                                                  ing post-translational switch mechanism. <br />                                        20 <br />                                                                                            CPT toxicity depends ability DNA repair systems <br />                                        15                                                  restore basic cellular functions. TopIB overexpres- <br />                                                                                            sion trigger repair mechanisms linked this <br />                                        10                                                  enzyme tyrosyl diphosphodiesterase I (TdpI), <br />                                                                                            prevents formation ternary complexes with <br />                                        5                                                   DNA presence CPT ubiquitination/ <br />                                                                                            sumoylation pathways [33]. Ubiquitination down- <br />                                        0 <br />                                                                                            regulation mechanism takes place hyper- <br />                                             0        20     40        60        80   100   phosphorylated enzyme. TopIB degradation 26S pro- <br />                                                                  Time (hours) <br />                                                                                            teasome useful increase tolerance DNA- <br />                                                                                            cleaving poisons, facilitating phosphodiesterase activ- <br /> &#206;&#8221; <br /> Figure <br /> strain   3 of <br />   topS+topS) <br />        (C)  tostrain <br /> Sensibility    L.the  (B) <br />                    major WTand <br />                      specific TopIB <br />                               (A), <br />                                the <br />                                    LmTopIB <br />                                     inhibitor <br />                                        rescued  (&#206;&#8221;topS/ <br />                                               CPT <br />                                               overexpresing <br /> Sensibility L. major WT (A), rescued (&#206;&#8221;topS/                                        ity Tdp1 excise Top1 cleaved DNA [34]. On the <br /> &#206;&#8221;topS+topS) strain (B) LmTopIB overexpresing                                       hand, sumoylation stimulatory system <br /> strain (C) specific TopIB inhibitor CPT. Cell density                               relocation TopIB nucleoplasm nucleo- <br /> was monitored growing concentrations: (m) control; (t)                                  lus preventing ubiquitin-mediated enzyme degrada- <br /> 0.125 &#206;&#188;M; (l) 0.25 &#206;&#188;M; (&#208;&#338;) 0.5 &#206;&#188;M; (n) 1 &#206;&#188;M; (h) 5 &#206;&#188;M                                  tion [35]. <br /> -25 (&#194;&#353;) &#206;&#188;M CPT Coulter. Experiments carried out <br /> by triplicate error bars represent standard deviations.                                Flow-cytometric analysis 12 h HU-arrested L. major pro- <br />                                                                                            mastigotes shows different cell-cycle recovering pattern <br />                                                                                            drug withdrawal. The LmTopIB-overexpressing strain <br /> obtained different strains, scarce differ-                                  shows S-phase delay cell cycle, fully <br /> ences accounted. One likely explanation find-                                 completed 24 h chemical arrest. On contrary, the <br /> ing possible degradation overexpressed                                       rescued-mutant (&#206;&#8221;topS/&#206;&#8221;topS) + topS completes cell <br /> subunit, unless assembled large subunit                                     cycle shorter period 9 h, hours WT. <br /> building active enzyme. There evidences showing                                     Synchronized L. major promastigotes exposed dif- <br />  <br />  <br />                                                                                                                                                Page 6 14 <br />                                                                                                                          (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                               http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                      A                                                         described CPT-mediated leishmanicidal effect L. <br />                                       Time (min)                               donovani promastigotes appears mitochondrial <br />                                   0.5 1   5 10 15 20   1   2   3   4   5   6   function inhibited, turn followed an <br />                 WT       N-                                                    increase mitochondrial membrane potential. These <br />                          R <br />                                                                                authors showed CPT increases intracellular con- <br />                                                                                centration reactive oxygen species (ROS), con- <br />                          S- <br />                                                                                comitant rise lipid peroxidation decline the <br />                                                                                concentration free radical scavenger glutathione. In <br />                                       Time (min) <br />                                                                                second report, authors described involvement <br />                      B <br />                                   0.5 1   5 10 15 20 <br />                                                                                caspase-3 poly-(ADP-ribose) polymerase (PARP) <br />                                                        1   2   3   4   5   6 <br /> LmTopIB overexpressing N - <br />                                                                                cleavage CPT-mediated apoptosis depletion of <br />                                                                                intracellular K+ DNA fragmentation, time <br />                          R                                                     span [40]. These results reproducible L. major <br />                                                                                promastigotes assay conditions expressed in <br />                          S- <br />                                                                                Materials Methods. Expanded time points con- <br />                                                                                centrations able produce effects described <br />                                       Time (min)                               authors. Unlike aforementioned results, <br />                      C            0.5 1   5 10 15 20   1   2   3   4   5   6   50% apoptosis early <br />     topS/ topS) + topS <br />                              N-                                                4-h exposure 5 &#206;&#188;M CPT, detect &#226;&#8364;&#8220; using <br />                                                                                PS/PI double stain assay &#226;&#8364;&#8220; scant 12% apoptosis after <br />                          R <br />                                                                                48 h exposure CPT. According current knowledge <br />                                                                                trypanosomatids genome, apoptosis pathway <br />                              S- <br />                                                                                described authors downstream CPT-induced ROS <br />                                                                                production, unlikely. No genes involved cas- <br /> genetically <br /> DNA <br /> Figurerelaxation <br />         4 manipulated <br />                  activityatofthe <br />                               thetopS <br />                                   L. major <br />                                       locusWT strain <br /> DNA relaxation activity L. major WT strain                      pase cascade PARP cleavage annotated in <br /> genetically manipulated topS locus. 0.2 Micrograms                   Leishmania genome Project metacaspase-like <br /> leishmanial extracts incubated 0.125 &#206;&#188;g RfI                       proteins recently described responsible cas- <br /> &#206;&#166;X174 supercoiled DNA 30 min 37&#194;&#176;C. Lanes 1 6                         pase-like activities PCD [37,41]. Time concentra- <br /> correspond time-course experiments (0.5, 1, 5, 10, 15, 20                   tion experiments showed episomal <br /> min). Lanes 7 12 correspond two-fold serial dilution                   overexpression complete LmTopIB poor <br /> assay leishmanial extracts. A) WT; B) LmTopIB-overex-                       impact CPT-mediated L. major apoptosis. These results <br /> presing strain; C) (&#206;&#8221;topS/&#206;&#8221;topS) + topS strain; N, nicked plas-                disagree previous experiments carried COS <br /> mid; R, relaxed plasmids; S, supercoiled plasmids.                             cells transfected yeast topIB encoding gene <br />                                                                                (ScTopIB), CPT treatment resulted preferential <br />                                                                                killing apoptosis cells expressing yeast <br /> ferent concentrations CPT period 24 h                     enzyme &quot;mock&quot; transfected cells [42]. A <br /> they washed incubated 48 h CPT-free                        possible explanation differences consist in <br /> medium. No differences detected dis-                          high differences relaxation activity (ca. 100-fold) <br /> tinct strains CPT concentrations submicromolar                        produced transient transfection ScTopIB gene in <br /> range. However, 1 &#206;&#188;M CPT produced S-phase delay WT                          COS cells. <br /> and (&#206;&#8221;topS/&#206;&#8221;topS) + topS strains reversible G2 arrest at <br /> 5 &#206;&#188;M CPT. The constant pressure (up 24 h) following                         Conclusion <br /> CPT removal induces activation S-phase check-                        The topS gene essential L. major survival, the <br /> point mammalian cells. Checkpoint activation pro-                           previous genetic rescue episomal plasmid carrying <br /> vides additional time DNA repair starting new                     topS gene necessary obtain complete double <br /> cell cycle [36]. Twenty hours 5 &#206;&#188;M CPT removal                      replacement topS alleles. Rescued (&#206;&#8221;topS/&#206;&#8221;topS) + <br /> results complete recovery cell cycle WT pro-                    topS LmTopIB-overexpressing strains charac- <br /> mastigotes, large percentage (&#206;&#8221;topS/&#206;&#8221;topS) + topS                     teristic phenotype relaxation activity CPT <br /> and      LmTopIB-overexpressing       promastigotes                      resistance. This lack phenotype post- <br /> remained arrested G2/M phase. However, 50 &#206;&#188;M CPT                            translational modifications threshold that <br /> produced clear irreversible arrest G2/M                      needed alter function reached. How- <br /> strains analyzed.                                                              ever, CPT treatment subsequent removal produced a <br />                                                                                recovery arrested cell-cycle G2/M, was <br /> Like DNA damaging agents, CPT efficient                            delayed overexpressing strain. The poor CPT- <br /> inducer PCD [37,38]. Sen coworkers [39]                            induced PCD observed L. major promastigote <br />  <br />  <br />                                                                                                                                   Page 7 14 <br />                                                                                                             (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                  http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                      0                20 nM               1 M                 5 M                   50 M <br />  <br />  <br />              WT <br />  <br />  <br />  <br />  <br /> LmTopIB-overexpressing <br />  <br />  <br />  <br />  <br />   ( topS/ topS) + topS <br />  <br />  <br />  <br />  <br /> FACS <br /> Figureanalysis <br />         5       cell cycle progression CPT-induced growth arrest L. major promastigotes <br /> FACS analysis cell cycle progression CPT-induced growth arrest L. major promastigotes. Dose-response effect of <br /> CPT-inducing cellular arrest. Fluorescence intensity representing cellular DNA content shown X axis, cell <br /> count shown Y axis. A total 20,000 events collected FACS analysis. The left-hand peak panel repre- <br /> sents G1 cells, right-hand peak represents G2 cells points between, represent S-phase cells. Exponential growing <br /> cultures treated indicated concentrations CPT 24 h (T24). After drug removal (by rinsing cultures in <br /> drug-free medium), cells incubated fresh medium 24 hours (R24) 48 hours (R48). Cells collected at <br /> each time point, DNA content analyzed. <br />  <br />  <br /> strains suggests alternative cytotoxic mechanisms          Genome Database [43]. The resulting fragment was <br /> than previously shown L. donovani.                      digested SmaI BamHI cloned expres- <br />                                                                  sion vector pXG [44] make pXG-topS. The integrity of <br /> Methods                                                          plasmid confirmed sequencing. <br /> Parasite cultures <br /> L. major LV39c5 promastigotes (WT strain) cultured          Two topS deletion constructs created: pSK-topS-KO- <br /> at 26&#194;&#176;C M199 supplemented 10% (v/v) heat-inac-           HYG pSK-topS-KO-PAC. The topS ORF upstream <br /> tivated fetal calf serum (FCS).                                  (UST) downstream (DST) sequences (1.0 kb each) <br />                                                                  amplified PCR using primers incorporated <br /> Drug solutions                                                   restriction sites suitable subsequent insertion the <br /> CPT (Sigma Chemical Co. St. Louis USA) dissolved          polylinker region pSK Bluescript (Stratagene) vector <br /> dimethylsulfoxide (DMSO) 20 mM final concentration            &quot;head-to-tail&quot; manner. The DNA fragments corre- <br /> and stored -20&#194;&#176;C.                                             sponding hygromycine B (HYG) puromycin (PAC) <br />                                                                  selection antibiotics based Leishmania expres- <br /> Cloning LdTopS LdTopL genes molecular                 sion vector series pXG-HYG pXG-PAC [45]. HYG and <br /> constructs                                                       PAC ORFs obtained digestion BamHI and <br /> The gene encoding catalytic subunit LmTopIB (topS         SpeI cloned UST DST sequences of <br /> a 789-bp fragment) amplified PCR L. major            topS ORF. The resulting constructs (pSK-topS-KO- <br /> genomic DNA using primers 5&apos;-tcccccgggccaccAT-               HYG, pSK-topS-KO-PAC) digested NotI- <br /> GCAGCCTGTTCAAAGTCCT-3&apos;,                    5&apos;-cgcggatcct-    EcoRV obtain linear topS deletion fragments (3.0 kb for <br /> caaaaatcgaagttctcggc-3&apos; (capitalized letters topS).     HYG-cassette 2.6 kb PAC-cassette, respectively). <br /> Sequence primers extracted L. major <br />  <br />  <br />                                                                                                                      Page 8 14 <br />                                                                                                (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                            http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                A                                  WT <br />                                     0 <br />  <br />  <br />  <br />  <br />                                    5 M <br />  <br />  <br />  <br />  <br />                                    50 M <br />  <br />  <br />  <br />                                               T24              R24             R48 <br />  <br />  <br />                                B                           LmTopIB-overexpressing <br />                                         0 <br />  <br />  <br />  <br />  <br />                                     5 M <br />  <br />  <br />  <br />  <br />                                     50 M <br />  <br />  <br />  <br />                                                 T24            T24            R48 <br />  <br />  <br />                                C <br />                                         0                        ( topS/ topS) + topS <br />  <br />  <br />  <br />  <br />                                     5 M <br />  <br />  <br />  <br />  <br />                                     50 M <br />  <br />  <br />  <br />                                                 T24             R24             R48 <br />  <br />  <br /> Figure <br /> The same6 experiment shown figure 5 performed <br /> The experiment shown figure 5 performed. B) WT; C) LmTopIB-overexpressing strain D) rescued <br /> (&#206;&#8221;topS/&#206;&#8221;topS) + topS strain. Cells collected time point, DNA content analyzed. <br />  <br />  <br />  <br />  <br />                                                                                                               Page 9 14 <br />                                                                                         (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                  http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />             WT               Reference              7               9               11              14                   24 h <br />           0 CPT <br />  <br />  <br />  <br />  <br />            WT <br />          5 M CPT <br />  <br />  <br />  <br />  <br />     LmTopIB-overexpressing <br />             0 CPT <br />  <br />  <br />  <br />  <br />     LmTopIB-overexpressing <br />           5 M CPT <br />  <br />  <br />  <br />  <br />     ( topS/ topS) +topS <br />            0 CPT <br />  <br />  <br />  <br />  <br />     ( topS/ topS) +topS <br />          5 M CPT <br />  <br />  <br />  <br />  <br /> Figure 7of DNA content L. major promastigotes reversible arrest HU <br /> Analysis <br /> Analysis DNA content L. major promastigotes reversible arrest HU. Cells obtained 12 h-arrest 5 mM <br /> HU (time 0) harvested incubated fresh media presence absence 5 &#206;&#188;M CPT. After time periods indi- <br /> cated, cells stained propidium iodide (PI) analyzed flow-cytometry. The graphs represent relative PI fluo- <br /> rescence plotted frequency events channel. Each plot represents data collected 20,000 events/sample. <br />  <br />  <br />  <br /> LmTopL encoding gene corresponds large DNA-               cytomix (120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4, <br /> binding subunit leishmanial TopIB. It amplified           25 mM Hepes pH 7.6, 2 mM EDTA, 5 mM MgCl2) [46] <br /> from L. major genomic DNA using oligonucleotides 5&apos;-         resuspended solution concentration <br /> tcccccgggccaccATGAAGGTGGAGAATAGCAAGATG-3&apos;                        1 &#195;&#8212; 108 promastigotes ml. Five hundred-microliter <br /> and 5&apos;-cgcggatccCTACACCCTCAAAGCTGCAAGAGG-3&apos;                      aliquots electroporated twice 5 &#206;&#188;g linear <br /> (capitalized letters topL). The resulting fragment      3.0-kb NotI-EcoRV topS::HYG fragment (1.5 kV, 25 &#206;&#188;F <br /> was digested SmaI-BamHI cloned                 using Bio-Rad Gene Pulser II apparatus) 0.4 cm elec- <br /> expression vector pXG-HYG, constituting plas-           trode gap cuvettes, transferred 10 ml M199 plus 10% <br /> mid pXG-HYG-topL. An overexpressing LmTopIB strain               FCS incubated 26&#194;&#176;C 8 h absence antibiot- <br /> was obtained double transformation pXG-topS              ics. Cells spun down, pellet resuspended <br /> and pXG-HYG-topL.                                                100 &#206;&#188;l fresh M199 plus 10% FCS plated sem- <br />                                                                  isolid medium containing 30 &#206;&#188;g/ml HYG. Heterozygotes <br /> Deletion L. major topS gene                               showing replacement alleles topS (+/-) <br /> In order replace topS allele, L. major WT promastig-    subjected second round gene disruption. <br /> otes, grown 5 &#195;&#8212; 106 ml, washed cold            With purpose, electroporated 5 &#206;&#188;g of <br />  <br />  <br />                                                                                                                     Page 10 14 <br />                                                                                                (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                 http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                          untreated   CPT 0.1 M                CPT 1 M               CPT 5 M                 CPT 10 M <br />        WT <br />  LmTopIB-overexpressig <br />   ( topS/ topS) + topS <br />  <br />  <br />  <br />  <br /> Figure <br /> were  treated <br />         8     as <br /> PS externalization different concentrations <br />                       consequence  CPTofexposure; <br />                                                CPT WT, <br />                                                        24 h analyzed PCD <br />                                                             LmTopIB-overexpressing rescued (&#206;&#8221;topS/&#206;&#8221;topS)+topS strains <br /> PS externalization consequence CPT exposure; WT, LmTopIB-overexpressing rescued (&#206;&#8221;topS/&#206;&#8221;topS)+topS strains <br /> were treated different concentrations CPT 24 h analyzed PCD. Dead cells excluded PI incorpora- <br /> tion. Dot plots representative independent assays. <br />  <br />  <br /> the 2.6-kb NotI-EcoRV topS::PAC fragment. Five clones            ml HYG, 10 &#206;&#188;g/ml G418 30 &#206;&#188;g/ml PAC selected <br /> (topS-1&#226;&#8364;&#8220;5) grew presence 30 &#206;&#188;g/ml HYG         rescued topS-null mutants (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC) + <br /> 30 &#206;&#188;g/ml PAC selected topS-null mutants                  topS, (this strain called: (&#206;&#8221;topS/&#206;&#8221;topS) + topS from <br /> (&#206;&#8221;topS::HYG/&#206;&#8221;topS::PAC). Successful integration          on), episomal plasmid pXG-topS. <br /> cassettes achieved clones. How- <br /> ever, replacement topS alleles incomplete      SDS-PAGE Western Blotting <br /> all clones.                                                  L. major promastigotes harvested different times <br />                                                                  growth washed twice PBS. After soni- <br /> A new approach double gene replacement car-         cation centrifugation 10,000 &#195;&#8212; g 20 min, the <br /> ried using topS heterozygous clones, trans-       supernatant removed. Five micrograms protein <br /> fected pXG-topS. Those clones resistant        time point diluted loading buffer <br /> 30 &#206;&#188;g/ml HYG 10 &#206;&#188;g/ml G418 selected                 (60 mM Tris-HCl, pH 6.8, 2% SDS, 5% 2-mercaptoetha- <br /> named (-/+)/+ topS. This new clone used perform           nol, 5% glycerol), boiled 5 min, analyzed by <br /> the second round gene disruption. Electroporation         SDS-PAGE (12% acrylamide, 2.7% bisacrylamide). Pro- <br /> performed 5 &#206;&#188;g 2.6-kb NotI-EcoRV topS::PAC           teins electrotransferred PVDF membranes <br /> fragment. Five clones grew presence 30 &#206;&#188;g/        (Sigma) 12 h 25&#226;&#8364;&#8220;30 V/cm, blots were <br />  <br />  <br />                                                                                                                    Page 11 14 <br />                                                                                               (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                       http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br />  <br />                                                                                    Time (hours) <br />  <br />                                                    24 <br />                                                    24                                   36 <br />                                                                                         36                                              48 <br />                                                                                                                                         48 <br />                            untreated <br />  wt <br />   LmTopIB-overexpressing <br />   ( TopS/ TopS) +topS <br />  <br />  <br />  <br />  <br /> Figure 9 <br /> Time-course  experiment PS externalization CPT exposure <br /> Time-course experiment PS externalization CPT exposure. WT, LmTopIB-overexpressing rescued (&#206;&#8221;topS/ <br /> &#206;&#8221;topS)+topS strains exposed 5 &#206;&#188;M CPT treatment 24, 36 48 h. PS externalization monitored FACS. <br /> Dead cells excluded PI incorporation. Dot plots representative independent assays. <br />  <br />  <br /> blocked incubation 10 mM Tris-HCl, pH 7.5, 1 M            manial lysates. Each reaction contained 125 ng super- <br /> NaCl, 0.5% Tween 20, 5% non-fat milk powder (w/v)           coiled close circular DNA virus &#206;&#166; X-174 (Rf I) in <br /> 1 h room temperature. Polyclonal primary rabbit anti-        20 &#206;&#188;l reaction buffer (100 mM KCl, 10 mM Tris-HCl, <br /> bodies L. donovani large LdTopIL, small LdTopIS <br /> subunits &#206;&#178;-actin added buffer            Platting cells <br />                                                                     24 hr <br />                                                                                                                         7   9 11   14        24 hr <br /> blot incubated 2 h. The filter washed thor-                                            12 hr   2 hr <br />  <br /> oughly 10 mM Tris-HCl, pH 7.5, 1 M NaCl, 0.5%                                                  HU 5mM <br /> Tween 20 incubated anti-rabbit anti-                                                             5    M CPT <br />                                                                                                                       75 min <br /> body conjugated horseradish peroxidase (Sigma Chem- <br /> ical Co. St. Louis USA). Antibodies detected using                                                Reference <br /> 3,3&apos;-diamino benzidine substrate (Biorad). <br />                                                                 Figure <br />                                                                 Scheme <br />                                                                 CPT treatment <br />                                                                        10 <br />                                                                        culture synchronization 5 mM HU and <br /> Assays TopIB-mediated relaxation plasmid DNA             Scheme culture synchronization 5 mM HU and <br /> The relaxation activity LmTopIB assayed           CPT treatment. <br /> indicated time points using 2-fold serial dilutions leish- <br />  <br />  <br />                                                                                                                                    Page 12 14 <br />                                                                                                       (page number citation purposes) <br />  BMC Microbiology 2008, 8:113                                                  http://www.biomedcentral.com/1471-2180/8/113 <br />  <br />  <br />  <br /> pH 7.5, 1 mM DTT, 1 mM EDTA). The reactions               Authors&apos; contributions <br /> incubated 37&#194;&#176;C 20 min stopped           RBF RMR conceived study, participated its <br /> addition 5 &#206;&#188;l 5 &#195;&#8212; stop buffer (2.5% SDS, 25 mM           design performed deletion complementation <br /> EDTA, 25% Ficoll 400, 0.08% bromophenol blue, 0.08%            LmTopS gene. YPP CGE participated con- <br /> xylene). The products analyzed electrophoresis      struction plasmids performed phenotypical <br /> 1% agarose gel, stained ethidium bromide, visu-       analyses. RBF, CGE, YPP RMR drafted manuscript <br /> alized UV transilluminator.                             RMR revised article. All authors read and <br />                                                                approved final manuscript. <br /> Flow-cytometric analysis DNA content <br /> For flow-cytometric analysis, 4 &#195;&#8212; 106 promastigotes       Acknowledgements <br /> harvested centrifugation 660 &#195;&#8212; g, washed twice      This research partially supported MEC (grant AGL2006-07420/ <br /> PBS, resuspended 1 ml fixative solution (30% PBS/        GAN) Instituto Salud Carlos III (grant PI06302 RICET) from <br /> 70% methanol) incubated 4&#194;&#176;C 1 h. Afterwards,        Ministerio Salud y Consumo Spanish Kingdom. <br /> parasites collected centrifugation, resuspended in <br /> PBS containing 20 &#206;&#188;g/ml RNaseA (Roche, Mannheim,            References <br />                                                                1.    Bailey M, Lockwood DN: Cutaneous leishmaniasis. Clin Dermatol <br /> Germany) incubated 20 min 37&#194;&#176;C. After incu-               2007, 25:203-211. <br /> bation, cells harvested, resuspended 1 ml       2.    Bala&#195;&#177;a-Fouce R, Cubr&#195;&#173;a JC, Reguera RM, Ord&#195;&#179;&#195;&#177;ez D: The pharma- <br />                                                                      cology leishmaniasis. Gen Pharmacol 1998, 30:435-443. <br /> citrate buffer (45 mM MgCl2, 30 mM sodium citrate, 20          3.    Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker <br /> mM Mops, pH 7.0, 0.1% Triton X-100), stained                  S: Cutaneous leishmaniasis. Lancet Infect Dis 2007, 7:581-596. <br /> the addition 50 &#206;&#188;g propidium iodide (PI) (Sigma, St.     4.    Berman J: Clinical status agents developed leish- <br />                                                                      maniasis. Expert Opin Invest Drugs 2005, 14:1337-1346. <br /> Louis, MO, U.S.A.) followed incubation 37&#194;&#176;C 20       5.    Mohebali M, Fotouhi A, Hooshmand B, Zarei Z, Akhoundi B, Rah- <br /> min. Fluorescence determined flow cytometry                nema A, Razaghian AR, Kabir MJ, Nadim A: Comparison milte- <br /> an FACSCalibur flow cytometer (Becton Dickinson, San                 fosine meglumine antimoniate treatment of <br />                                                                      zoonotic cutaneous leishmaniasis (ZCL) randomized <br /> Jose, CA, U.S.A.).                                                   clinical trial Iran. Acta Trop 2007, 103:33-40. <br />                                                                6.    Champoux JJ: DNA topoisomerases: Structure, function, and <br />                                                                      mechanism. Ann Rev Biochem 2001, 70:369-413. <br /> Cell cycle synchronization CPT treatment                   7.    Wang JC: Cellular roles DNA topoisomerases: A molecular <br /> For synchronization DNA replication, exponen-                 perspective. Nat Rev Mol Cell Biol 2002, 3:430-440. <br /> tially growing L. major promastigotes (5 &#195;&#8212; 106 cells/ml)       8.    Corbett KD, Berger JM: Structure, molecular mechanisms, and <br />                                                                      evolutionary relationships DNA topoisomerases. Ann Rev <br /> were arrested 5 mM hydroxyurea (HU) 12 h.                   Biophys Biomol Struct 2004, 33:95-118. <br /> Afterwards parasites harvested, washed twice         9.    Bakshi RP, Shapiro TA: DNA topoisomerases targets anti- <br />                                                                      protozoal chemotherapy. Mini Rev Med Chem 2003, 3:597-608. <br /> PBS resuspended fresh medium 2 h use.        10.   Reguera RM, Redondo CM, Gutierrez Prado R, Perez-Pertejo Y, <br /> Cells treated 5 &#206;&#188;M CPT 75 min                 Bala&#195;&#177;a-Fouce R: DNA-topoisomerase I parasitic proto- <br /> finally incubated CPT-free medium time indi-            zoa: potential target chemotherapy. Biochim Biophys Acta <br />                                                                      2006, 1759:117-131. <br /> cated scheme Figure 10.                              11.   Bala&#195;&#177;a-Fouce R, Redondo CM, P&#195;&#169;rez-Pertejo Y, Diaz-Gonz&#195;&#161;lez R, <br />                                                                      Reguera RM: Targeting atypical trypanosomatid DNA topoi- <br /> Determination apoptosis                                           somerase I. Drug Discov Today 2006, 11:733-740. <br />                                                                12.   Villa H, Otero-Marcos AR, Reguera RM, Bala&#195;&#177;a-Fouce R, Garc&#195;&#173;a- <br /> Apoptosis detected translocation phosphatidyl              Estrada C, P&#195;&#169;rez-Pertejo Y, Tekwani BL, Myler PJ, Stuart KD, Bjornsti <br /> serine (PS) cell surface annexin V-FITC rea-         MA, Ord&#195;&#179;&#195;&#177;ez D: A novel active DNA topoisomerase I Leish- <br />                                                                      mania donovani. J Biol Chem 2003, 278:3521-3526. <br /> gent (BD Pharmigen). Fraction annexin V-positive cells      13.   Bodley AL, Chakraborty AK, Xie S, Burri C, Shapiro TA: An unusual <br /> was measured CellQuest software (BD Biosciences,                type IB topoisomerase African trypanosomes. Proc Natl <br /> San Jose, CA).                                                       Acad Sci USA 2003, 100:7539-7544. <br />                                                                14.    [http://www.tigr.org/tdb/e2k1/tca1]. <br />                                                                15.   Lee MP, Brown SD, Chen A, Hsieh TS: DNA topoisomerase I is <br /> List abbreviations                                                essential Drosophila melanogaster. Proc Natl Acad Sci USA <br />                                                                      1993, 90:6656-6660. <br /> Camptothecin (CPT); dimethylsulfoxide (DMSO); exter-           16.   Morham SG, Kluckman KD, Voulomanos N, Smithies O: Targeted <br /> nal probe (EP); Fluorescence Activated Cell Sorting                  disruption mouse topoisomerase I gene camp- <br /> (FACS); Fetal Calf Serum (FCS); hydroxyurea (HU);                    tothecin selection. Mol Cell Biol 1996, 16:6804-6809. <br />                                                                17.   Wang Z, Englund PT: RNA interference trypanosome <br /> hygromycine B (HYG); large subunit leishmanial DNA                topoisomerase II causes progressive loss mitochondrial <br /> topoisomerase (LmTopIL); small subunit leishmanial                DNA. EMBO J 2001, 20:4674-4683. <br /> DNA topoisomerase (LmTopIS); puromycin (PAC); Poly-            18.   Bakshi RP, Shapiro TA: RNA interference Trypanosoma bru- <br />                                                                      cei topoisomerase IB: Both subunits essential. Mol Bio- <br /> (ADP-ribose)-polymerase (PARP); Programmed Cell                      chem Parasitol 2004, 136:249-255. <br /> Death (PCD); propidium iodide (PI); phosphatidylserine         19.   Pommier Y: Topoisomerase I inhibitors: Camptothecins and <br />                         <br /> </body></html>